Structural integrity of white matter tracts as a predictor of acute ischemic stroke outcome.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 3 4 2020
medline: 26 10 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

Clinical assessment scores in acute ischemic stroke are only moderately correlated with lesion volume since lesion location is an important confounding factor. Many studies have investigated gray matter indicators of stroke severity, but the understanding of white matter tract involvement is limited in the early phase after stroke. This study aimed to measure and model the involvement of white matter tracts with respect to 24-h post-stroke National Institutes of Health Stroke Scale (NIHSS). A total of 96 patients (50 females, mean age 66.4 ± 14.0 years, median NIHSS 5, interquartile range: 2-9.5) with follow-up fluid-attenuated inversion recovery magnetic resonance imaging data sets acquired one to seven days after acute ischemic stroke onset due to proximal anterior circulation occlusion were included. Lesions were semi-automatically segmented and non-linearly registered to a common reference atlas. The lesion overlap and tract integrity were determined for each white matter tract in the AALCAT atlas and used to model NIHSS outcomes using a supervised linear-kernel support vector regression method, which was evaluated using leave-one-patient-out cross validation. The support vector regression model using the tract integrity and tract lesion overlap measurements predicted the 24-h NIHSS score with a high correlation value of r = 0.7. Using the tract overlap and tract integrity feature improved the modeling accuracy of NIHSS significantly by 6% (p < 0.05) compared to using overlap measures only. White matter tract integrity and lesion load are important predictors for clinical outcome after an acute ischemic stroke as measured by the NIHSS and should be integrated for predictive modeling.

Sections du résumé

BACKGROUND AND PURPOSE
Clinical assessment scores in acute ischemic stroke are only moderately correlated with lesion volume since lesion location is an important confounding factor. Many studies have investigated gray matter indicators of stroke severity, but the understanding of white matter tract involvement is limited in the early phase after stroke. This study aimed to measure and model the involvement of white matter tracts with respect to 24-h post-stroke National Institutes of Health Stroke Scale (NIHSS).
MATERIAL AND METHODS
A total of 96 patients (50 females, mean age 66.4 ± 14.0 years, median NIHSS 5, interquartile range: 2-9.5) with follow-up fluid-attenuated inversion recovery magnetic resonance imaging data sets acquired one to seven days after acute ischemic stroke onset due to proximal anterior circulation occlusion were included. Lesions were semi-automatically segmented and non-linearly registered to a common reference atlas. The lesion overlap and tract integrity were determined for each white matter tract in the AALCAT atlas and used to model NIHSS outcomes using a supervised linear-kernel support vector regression method, which was evaluated using leave-one-patient-out cross validation.
RESULTS
The support vector regression model using the tract integrity and tract lesion overlap measurements predicted the 24-h NIHSS score with a high correlation value of r = 0.7. Using the tract overlap and tract integrity feature improved the modeling accuracy of NIHSS significantly by 6% (p < 0.05) compared to using overlap measures only.
CONCLUSION
White matter tract integrity and lesion load are important predictors for clinical outcome after an acute ischemic stroke as measured by the NIHSS and should be integrated for predictive modeling.

Identifiants

pubmed: 32233745
doi: 10.1177/1747493020915251
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

965-972

Auteurs

Deepthi Rajashekar (D)

Biomedical Engineering Graduate Program, University of Calgary, Calgary, AB, Canada.
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
157742Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Pauline Mouchès (P)

Biomedical Engineering Graduate Program, University of Calgary, Calgary, AB, Canada.
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
157742Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Jens Fiehler (J)

Department of Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Bijoy K Menon (BK)

Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
157742Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

Mayank Goyal (M)

Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
157742Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Andrew M Demchuk (AM)

Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
157742Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Michael D Hill (MD)

Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
157742Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Sean P Dukelow (SP)

Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

Nils D Forkert (ND)

Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
157742Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH